Celltrion Gets FDA Nod For Subcutaneous Infliximab

Zymfentra, Marketed Globally As Remsima SC, Receives Approval In US

 
• By Dave Wallace
  
Sign outside of FDA's headquarters in White Oak, MD
Celltrion has received FDA approval for its subcutaneous infliximab • Source: Alamy

More from Biosimilars

More from Products